Registry of Lobbyists
Version 1 of 41 (2007-04-27 to 2007-11-08) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
Pfizer Canada ULC
17,300 TRANS-CANADA HIGHWAY KIRKLAND, QC H9J 2M5 Canada |
| Telephone number: | 514-426-7417 |
| Fax number: | 514-426-6835 |
| Responsible officer name and position during the period of this registration: | Paul Lévesque, Président et chef de la direction |
| Description of activities: | Research, development, manufacture, marketing and sale of pharmaceuticals, animal health products. |
| The client is a subsidiary of the following parent companies: |
PFIZER INC
235 EAST 42ND STREET NEW YORK, NY United States of America 10017-5755 |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | John Carkner |
| Position title: | Site Leader, Technical Director |
| Public offices held: | No |
| Name: | Nicolas Gagnon |
| Position title: | Manager, Pricing |
| Public offices held: | Yes |
| Name: | Vratislav Hadrava |
| Position title: | Director, Regulatory Affairs & Safety |
| Public offices held: | No |
| Name: | John Helou |
| Position title: | Vice President, Public Affairs & Stakeholder Relations |
| Public offices held: | No |
| Name: | Steven Hogue |
| Position title: | Manager, Federal Relations |
| Public offices held: | Yes |
| Name: | Maria Klapka |
| Position title: | Director, Regulatory Policy & Intelligence |
| Public offices held: | No |
| Name: | Paul Lévesque |
| Position title: | President & CEO |
| Public offices held: | No |
| Name: | David Malian |
| Position title: | Director, Government & Professional Affairs |
| Public offices held: | No |
| Name: | Madeleine Pesant |
| Position title: | Associate Director, Regulatory Policy & Intelligence |
| Public offices held: | No |
| Name: | Bernard Prigent |
| Position title: | Vice President and Medical Director |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Agriculture and Agri-Food Canada (AAFC), Competition Tribunal (CT), Environment Canada, Federal Office of Regional Development – Quebec (FORD[Q]), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Immigration and Refugee Board (IRB), Industry Canada, National Defence (DND), Office of the Information and Privacy Commissioner (OIPC), Parliament, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Revenue Canada (RC), Royal Canadian Mounted Police (RCMP), Solicitor General Canada (SGC), Treasury Board Of Canada Secretariat (TBS), Veterans Affairs Canada (VAC) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication, Informal communications, Meetings, Other types: As part of Industry Associations and Delegations eg. Rx&D, BIOTECanada, Chamber of Commerce, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Areas of Concern: | Aboriginal Affairs, Access to Information, Agriculture, Competition Law, Consumer Issues, Cross-border Trade, Education, Environment, Federally-funded Health Benefits Program, Health, Immigration, Industry, Intellectual Property, Inter-governmental Affairs, Internal Trade, International Trade, Pharmaceutical Pricing Regulation, Regional Development, Research Funding, Research Policies, Regulations and Ethnics, Science and Technology, Taxation and Finance, Veterans Affairs (Medication Procurement, Health Partnership, Pharmaceutical Policy), Veterinary Biologics, Veterinary Drugs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Retrospective: | Informal communications, phone calls, written communications, meetings, presentations with: ministers, members of parliament, senators, political advisors and civil servants. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Subject Matter: Prospective: | Informal communications, phone calls, written communications, meetings, presentations with: ministers, members of parliament, senators, political advisors and civil servants. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details Regarding the Identified Subject Matter
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||